Reanalyses of Randomized Clinical Trial Data

被引:127
|
作者
Ebrahim, Shanil [1 ,2 ,3 ,4 ]
Sohani, Zahra N. [2 ,5 ]
Montoya, Luis [6 ]
Agarwal, Arnav [7 ]
Thorlund, Kristian [1 ,2 ]
Mills, Edward J. [1 ,2 ,8 ]
Ioannidis, John P. A. [1 ,9 ,10 ,11 ]
机构
[1] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
[2] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
[3] McMaster Univ, Dept Anesthesia, Hamilton, ON L8S 4L8, Canada
[4] Hosp Sick Children, Dept Anaesthesia & Pain Med, Toronto, ON M5G 1X8, Canada
[5] McMaster Univ, Populat Genom Program, Hamilton, ON L8S 4L8, Canada
[6] Univ Hlth Network, Toronto, ON, Canada
[7] McMaster Univ, Fac Hlth Sci, Hamilton, ON L8S 4L8, Canada
[8] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada
[9] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[10] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA
[11] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA
来源
基金
加拿大健康研究院;
关键词
PERIPHERAL NEUROPATHY; EFFICACY CRITERIA; NATIONAL-SURVEY; ACUPUNCTURE; GENETICS; SCIENCE; DISEASE; MODEL;
D O I
10.1001/jama.2014.9646
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Reanalyses of randomized clinical trial (RCT) data may help the scientific community assess the validity of reported trial results. OBJECTIVES To identify published reanalyses of RCT data, to characterize methodological and other differences between the original trial and reanalysis, to evaluate the independence of authors performing the reanalyses, and to assess whether the reanalysis changed interpretations from the original article about the types or numbers of patients who should be treated. DESIGN We completed an electronic search of MEDLINE from inception to March 9, 2014, to identify all published studies that completed a reanalysis of individual patient data from previously published RCTs addressing the same hypothesis as the original RCT. Four data extractors independently screened articles and extracted data. MAIN OUTCOMES AND MEASURES Changes in direction and magnitude of treatment effect, statistical significance, and interpretation about the types or numbers of patients who should be treated. RESULTS We identified 37 eligible reanalyses in 36 published articles, 5 of which were performed by entirely independent authors (2 based on publicly available data and 2 on data that were provided on request; data availability was unclear for 1). Reanalyses differed most commonly in statistical or analytical approaches (n = 18) and in definitions or measurements of the outcome of interest (n = 12). Four reanalyses changed the direction and 2 changed the magnitude of treatment effect, whereas 4 led to changes in statistical significance of findings. Thirteen reanalyses (35%) led to interpretations different from that of the original article, 3 (8%) showing that different patients should be treated; 1 (3%), that fewer patients should be treated; and 9 (24%), that more patients should be treated. CONCLUSIONS AND RELEVANCE A small number of reanalyses of RCTs have been published to date. Only a few were conducted by entirely independent authors. Thirty-five percent of published reanalyses led to changes in findings that implied conclusions different from those of the original article about the types and number of patients who should be treated.
引用
收藏
页码:1024 / 1032
页数:9
相关论文
共 50 条
  • [1] Contribution of Clinical Trial Event Data by Data Source A Prespecified Analysis of the ADAPTABLE Randomized Clinical Trial
    Rymer, Jennifer A.
    Mulder, Hillary
    Wruck, Lisa M.
    Munoz, Daniel
    Kripalani, Sunil
    Effron, Mark B.
    Gupta, Kamal
    Handberg, Eileen
    Jain, Sandeep
    Girotra, Saket
    Whittle, Jeffrey
    Hess, Rachel
    Benziger, Catherine P.
    Knowlton, Kirk U.
    Curtis, Lesley H.
    Roe, Matthew T.
    Hammill, Bradley G.
    Rothman, Russell L.
    Harrington, Robert
    Hernandez, Adrian
    Jones, W. Schuyler
    JAMA CARDIOLOGY, 2024, 9 (09) : 852 - 857
  • [2] Subgroup identification from randomized clinical trial data
    Foster, Jared C.
    Taylor, Jeremy M. G.
    Ruberg, Stephen J.
    STATISTICS IN MEDICINE, 2011, 30 (24) : 2867 - 2880
  • [3] Reanalyses of Trial Results
    Platts-Mills, Timothy F.
    Jones, Christopher W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (01): : 92 - 93
  • [4] Data Sharing and Reanalyses Among Randomized Clinical Trials Published in Surgical Journals Before and After Adoption of a Data Availability and Reproducibility Policy
    Bergeat, Damien
    Lombard, Nicolas
    Gasmi, Anis
    Le Floch, Bastien
    Naudet, Florian
    JAMA NETWORK OPEN, 2022, 5 (06)
  • [5] Analysis of messy longitudinal data from a randomized clinical trial
    Qian, W
    Parmar, MKB
    Sambrook, RJ
    Fayers, PM
    Girling, DJ
    Stephens, RJ
    STATISTICS IN MEDICINE, 2000, 19 (19) : 2657 - 2674
  • [6] Reanalyses of Trial Results Reply
    Ebrahim, Shanil
    Ioannidis, John P. A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (01): : 93 - 93
  • [7] Randomized clinical trial
    Bollo, Jesus
    Fernandez-Ananin, Sonia
    Targarona, Eduard
    CIRUGIA ESPANOLA, 2022, 100 (07): : 442 - 444
  • [8] The randomized clinical trial
    Harrington, DP
    JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2000, 95 (449) : 312 - 315
  • [9] RANDOMIZED CLINICAL TRIAL
    GLASER, EM
    NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (16): : 826 - +
  • [10] RANDOMIZED CLINICAL TRIAL
    INGELFINGER, FJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (02): : 100 - +